Voting for the @ASCO election will close soon I am honored to be running as one of the candidates for the Designated International Oncologist post Visit https://t.co/W5QYI9oG9I to learn about all of us who are running in the election & place your voteIt just takes 2 mins to vote.

What is Ovarian Cancer? This JAMA Patient Page breaks it down very clearly and in a simple way. @JAMA_current

Birmingham’s health and life sciences district is emerging as a powerful engine for growth - driving jobs, inward investment and globally-relevant research. Read @unibirm_CMH's Prof Neil Hanley's thoughts on how we're helping to strengthen the sector 👇 https://t.co/qmeg3Nvq0T

🏆 Double success at Innovation Awards! 🏆 Congratulations to CEO @gino_prof and @AlexRichter3, Director of @CISUoB, who last week won the Lifetime Achievement Award and Female Innovator of the Year at the @InnovAwards, recognising their impactful work 👏 https://t.co/0oLYRL6qEV

Congratulations Lorenzo Tucci @DocTux92 and @uhbtrust @UHBCancer @UoB_MSS @UoBmedicalsci @Bham_AT. Thanks for putting together this interesting case series about long-term treatment with #mitotane in patients with #adrenalcancer #adrenocorticalcarcinoma

Want to know how you can raise awareness of ovarian cancer? You can: 👉Share our symptoms information on social media. 👉Join us as a campaigner. We have a toolkit for you. 👉Share symptoms information in person with our range of posters Check them out: https://t.co/EV54UCQT3s

A heartfelt thank you to Dr. Ros Glasspool for your dedicated leadership as IGCS Advocacy Chair.   Your efforts have amplified the voice of patients and advocates worldwide and strengthened our global advocacy network.   Your impact will continue to inspire meaningful change

Extraordinary words by Sir John Major on #Brexit at LSE last night: 🧵 🇬🇧 🇪🇺 1. “In an act of collective folly, the United Kingdom voted to lead to European Union across the world, our enemies celebrated and our friends despair.” “We left Europe on a minority vote of 37% of

Thank you, Dr. Paul Cohen, for your outstanding leadership as IGCS Education Chair.   Your passion for global learning and equitable access to education has helped empower clinicians and advocates worldwide.   We are grateful for your vision, mentorship, and service to the IGCS

See you in Montreal for #IGCS2026!

What an inspiring few days in Cape Town at #IGCS2025! We loved sharing findings from the Every Woman Study™ and meeting so many passionate people dedicated to improving care and outcomes for women with gynecologic cancers around the world. #EvidenceToAction #NoWomanLeftBehind

Zero hesitation as ever to say what needs to be said. Had many colleagues across @NHSEngland today-distraught as to how things have unfolded regards their jobs, the media depiction of them and little to no regard to wellbeing Which would come as little surprise to many doctors.

Really important background to the crisis at the BBC:

WOW! Thanks to everyone who spread the word on social media about #IGCS2025! The hashtag was used over 1,250 times and had OVER 2 MILLION IMPRESSIONS! Special thanks to our top influencers: Salome Maswime, Angeles Alvarez-Secord, Hadi Erfani, Aisha Mustapha, Dee Sparacio, Mario

#IGCS2025 Congratulations Dr. Gourley!! OS improved in LGSC even with 72% crossover💕 ❤️💕GOG-281 tremendous study 🥰 @GOG

#IGCS Congratulations Dr Aletti - the TRUST trial. How to preoperatively identify patients most likely to benefit? PFS matters, right? Let the debates begin 😘

#IGCS2025 Congratulations Dr. Sundar!! for your tireless research to diagnose cancer and improve outcomes

And amazing work with the Duke angiome analysis to investigate who responds to Bev in recurrent cervix cancer @AngelesSecord very important question to answer!

#IGCS2025 Congratulations Dr Adams!! The Every Woman Study - Chilling results and an urgent call for action!! To address these inequities across care from surgery, treatment, genetic testing and clinical trial enrollment 😳

#IGCS2025 congratulations Dr Nakisige!! On your amazing work to improve screening implementation ❤️ and follow up. 20% HPV+ did not present for follow up - in part needed husband approval. More funding needed!! More vaccination - 🙏